Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Array BioPharma Inc

+ Add to Watchlist

ARRY:US

7.4000 USD 0.0700 0.95%

As of 20:10:00 ET on 03/27/2015.

Snapshot for Array BioPharma Inc (ARRY)

Open: 7.3400 Day's Range: 7.2600 - 7.4800 Volume: 1,290,479
Previous Close: 7.3300 52wk Range: 2.9800 - 8.5900 1-Yr Rtn: +65.55%

Stock Chart for ARRY

No chart data available.
  • ARRY:US 7.4000
  • 1D
  • 1M
  • 1Y
7.3300
Interactive ARRY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARRY

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6900
Est. EPS (USD) (06/2015) -0.1650
Est. PEG Ratio -
Market Cap (M USD) 1,033.76
Shares Outstanding (M) 139.70
30 Day Average Volume 2,472,467
Price/Book (mrq) -
Price/Sale (ttm) 20.7542
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARRY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARRY

Array BioPharma Inc., a discovery research company, creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies.

Ron SquarerChief Executive OfficerDavid Jay HorinInterim CFO
Victor SandorChief Medical OfficerNicholas A SaccomanoChief Scientific Officer
More Company Profile & Key Executives for ARRY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil